Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Chicago › NPI 1285302273
Lab

Western Labs Company

Western Labs Company was paid $8K by Medicaid between May 2022 and May 2023, across 5 billing codes. Its largest line is K1034, Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count — 76% of everything it billed.

33Billing provider infoWESTERN LABS COMPANY
CHICAGO, IL 60612
33aNPI1285302273assigned 09/02/2021
28Total paid$8K
24GClaims2,982
24DCodes billed5
24AFirst – last monthMay 2022 – May 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#177 of 235
Median peer was paid$123K
This provider vs. median0.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official AHMED, SYED controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K$6.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2022118$2K
20232,864$6K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count 76% 2,864 2,813 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 11% 26 26 $918.60
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6.7% 52 26 $564.81
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 6.0% 26 26 $506.82
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 14 14 $25.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAHMED, SYED (OPERATIONS MANAGER)
Same official

Other billing entities under AHMED, SYED

Full network →
ProviderLocationPaid
Healthway Internal Medicine & Pediatrics PLLCElizabethtown, KY$2.63M
Elite Endoscopy LLCLas Vegas, NV$1000K
Nephrology Associates of the Carolinas, P.A.Shelby, NC$785K
Antelope Valley Lung & Sleep Institute, INCPalmdale, CA$725K
Cleveland Psychiatry Associates LLCBrecksville, OH$517K
S H Ahmed MD PHD INCEl Centro, CA$483K
Av Intensivist Group INCPalmdale, CA$93K
Zeedoc,llcLas Vegas, NV$65K
Capital Internal Medicine & Geriatrics, P.A.Raleigh, NC$61K
Psychiatric Care INCFredericksburg, VA$54K
Advance Lab CompanyChicago, IL$1K
Vital Signs Physicians FL PLKissimmee, FL$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.